TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CRYPTOMAP

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CRYPTOMAP

ST13

US500000098748841

Classe

1, 5, 42, 44

Pedido

98748841

Registro

7898128

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

20

Atualização mais recente

19/08/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

13/09/2024

Data de registro

19/08/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

19/08/2025

Última transação

19/08/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

16

Localização do titular

Cambridge, GB

Examinador

OAKES, JEFFREY

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Epitopea Ltd.
Epitopea Inc.

Representantes

Scott D. Locke Dorf Nelson & Zauderer LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicals, reagents and substances, being diagnostic reagents, buffers, nucleic acids, peptides, antibodies and immunological peptides for medical research; antibodies for scientific purposes; immunoassay reagents, other than for medical or veterinary use; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use composed primarily of nucleic acids, peptides, antibodies, buffers and reagents; proteins, namely, monoclonal and polyclonal antibodies, and immunological peptides for scientific or research use; nucleotides for scientific and research use

Classe 5

Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic uses, namely, protein arrays for medical diagnosis purposes; diagnostic reagents for medical use; diagnostic and testing preparations for clinical, medical and medical laboratory use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in oncology and immunology testing for medical purposes; diagnostic test kits for medical purposes, namely, diagnostic kits comprising diagnostic agents, preparations and substances for medical use; antibodies for medical purposes; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use

Classe 42

Research and development in the fields of medicine in the nature of oncology and immunology; scientific research for medical purposes in the field of oncology; mining in the field of biology; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data on oncology and immunology; biomedical research services conducted using databases; consultancy, information and advisory services in the fields of oncology and immunology

Classe 44

Services in the field of oncology and immunology, namely, medical analysis services for the diagnosis of cancer and immunological disorders; medical screening services in the fields of oncology and immunology.

Publicações

Histórico de despachos e eventos da marca no USPTO.

20 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

19/08/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

19/08/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/06/2025

PUBO

PUBLISHED FOR OPPOSITION

03/06/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

28/05/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

09/05/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

25/04/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

25/04/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

25/04/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

25/04/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

25/04/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/04/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/04/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/04/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/03/2025

GNRT

NON-FINAL ACTION E-MAILED

21/03/2025

CNRT

NON-FINAL ACTION WRITTEN

21/03/2025

DOCK

ASSIGNED TO EXAMINER

13/03/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/01/2025

NWAP

NEW APPLICATION ENTERED

13/09/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CRYPTOMAP ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.